BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10198735)

  • 1. Periprocedural creatine kinase-MB elevations: long-term impact and clinical implications.
    Adgey AA; Mathew TP; Harbinson MT
    Clin Cardiol; 1999 Apr; 22(4):257-65. PubMed ID: 10198735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myonecrosis after revascularization procedures.
    Califf RM; Abdelmeguid AE; Kuntz RE; Popma JJ; Davidson CJ; Cohen EA; Kleiman NS; Mahaffey KW; Topol EJ; Pepine CJ; Lipicky RJ; Granger CB; Harrington RA; Tardiff BE; Crenshaw BS; Bauman RP; Zuckerman BD; Chaitman BR; Bittl JA; Ohman EM
    J Am Coll Cardiol; 1998 Feb; 31(2):241-51. PubMed ID: 9462562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with the release of cardiac troponin T following percutaneous transluminal coronary angioplasty.
    Abbas SA; Glazier JJ; Wu AH; Dupont C; Green SF; Pearsall LA; Waters DD; McKay RG
    Clin Cardiol; 1996 Oct; 19(10):782-6. PubMed ID: 8896910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between periprocedural myocardial infarction and subsequent target vessel revascularization following percutaneous coronary revascularization: insights from the EPIC trial. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications.
    Narins CR; Miller DP; Califf RM; Topol EJ
    J Am Coll Cardiol; 1999 Mar; 33(3):647-53. PubMed ID: 10080464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II.
    Tardiff BE; Califf RM; Tcheng JE; Lincoff AM; Sigmon KN; Harrington RA; Mahaffey KW; Ohman EM; Teirstein PS; Blankenship JC; Kitt MM; Topol EJ
    J Am Coll Cardiol; 1999 Jan; 33(1):88-96. PubMed ID: 9935014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial infarction as a complication of new interventional devices.
    Waksman R; Ghazzal ZM; Baim DS; Steenkiste AR; Yeh W; Detre KM; King SB
    Am J Cardiol; 1996 Oct; 78(7):751-6. PubMed ID: 8857477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade.
    Lincoff AM; Tcheng JE; Califf RM; Kereiakes DJ; Kelly TA; Timmis GC; Kleiman NS; Booth JE; Balog C; Cabot CF; Anderson KM; Weisman HF; Topol EJ
    Circulation; 1999 Apr; 99(15):1951-8. PubMed ID: 10208997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT).
    Harrington RA; Lincoff AM; Califf RM; Holmes DR; Berdan LG; O'Hanesian MA; Keeler GP; Garratt KN; Ohman EM; Mark DB
    J Am Coll Cardiol; 1995 Jun; 25(7):1693-9. PubMed ID: 7759725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial.
    Blankenship JC; Tasissa G; O'Shea JC; Iliadis EA; Bachour FA; Cohen DJ; Lui HK; Mann T; Cohen E; Tcheng JE;
    J Am Coll Cardiol; 2001 Sep; 38(3):653-8. PubMed ID: 11527612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of non-Q wave myocardial infarction after directional atherectomy is platelet dependent: evidence from the EPIC trial. Evaluation of c7E3 for the Prevention of Ischemic Complications.
    Lefkovits J; Blankenship JC; Anderson KM; Stoner GL; Talley JD; Worley SJ; Weisman HF; Califf RM; Topol EJ
    J Am Coll Cardiol; 1996 Oct; 28(4):849-55. PubMed ID: 8837559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy.
    Gibson CM; Murphy SA; Marble SJ; Cohen DJ; Cohen EA; Lui HK; Young J; Kitt MM; Lorenz TJ; Tcheng JE
    Am Heart J; 2002 Jan; 143(1):106-10. PubMed ID: 11773919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic significance of the elevation of the indices of myocardial damage after percutaneous coronary revascularization interventions].
    Cavallini C; Savonitto S
    Ital Heart J Suppl; 2002 Mar; 3(3):286-96. PubMed ID: 12040844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting.
    Saucedo JF; Mehran R; Dangas G; Hong MK; Lansky A; Kent KM; Satler LF; Pichard AD; Stone GW; Leon MB
    J Am Coll Cardiol; 2000 Apr; 35(5):1134-41. PubMed ID: 10758952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure.
    Abdelmeguid AE; Whitlow PL; Sapp SK; Ellis SG; Topol EJ
    Circulation; 1995 Jun; 91(11):2733-41. PubMed ID: 7758178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting.
    Kugelmass AD; Cohen DJ; Moscucci M; Piana RN; Senerchia C; Kuntz RE; Baim DS
    Am J Cardiol; 1994 Oct; 74(8):748-54. PubMed ID: 7942542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictive elements and prevention of myocardial damage during angioplasty/stenting].
    Bossi I; Savonitto S; Cavallini C; Delgado A; Pirola R; Klugmann S
    Ital Heart J Suppl; 2002 Mar; 3(3):275-85. PubMed ID: 12040843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cardiac troponin T and I and CK-MB for the detection of minor myocardial damage during interventional cardiac procedures.
    Harris BM; Nageh T; Marsden JT; Thomas MR; Sherwood RA
    Ann Clin Biochem; 2000 Nov; 37 ( Pt 6)():764-9. PubMed ID: 11085620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of eptifibatide on angiographic complications during percutaneous coronary intervention in the IMPACT--(Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis) II Trial.
    Blankenship JC; Sigmon KN; Pieper KS; O'Shea C; Tardiff BE; Tcheng JE;
    Am J Cardiol; 2001 Nov; 88(9):969-73. PubMed ID: 11703991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting.
    Shyu KG; Kuan PL; Cheng JJ; Hung CR
    Am Heart J; 1998 May; 135(5 Pt 1):862-7. PubMed ID: 9588418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.